activity
20232026
collaborators

5 papers

stat.AP2026

Synergy Area with FDR-controlled Evaluation (SAFE) to robustly assess safety profile in clinical trials

Tianyu Zhan, Yabing Mai, Yihua Gu +2

Safety assessment plays a fundamental role in developing a new drug via clinical trials for ethical considerations. Due to complexity, manual review is typically conducted on the t…

stat.ME2025

An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing with Concurrent Controls in Platform Trials

Tianyu Zhan, Jane Zhang, Lei Shu +1

A platform trial with a master protocol provides an infrastructure to ethically and efficiently evaluate multiple treatment options in multiple diseases. Given that certain study d…

stat.ME2025

Semiparametric Weighted Spline Regression (SWSR) in Confirmatory Clinical Trials with Time-Varying Placebo Effects

Tianyu Zhan, Yihua Gu

In confirmatory Phase 3 clinical trials with recruitment over the years, the underlying placebo effect may follow an unknown temporal trend. Taking a clinical trial on Hidradenitis…

stat.ME2025

A general, flexible and harmonious framework to construct interpretable functions in regression analysis

Tianyu Zhan, Jian Kang

An interpretable model or method has several appealing features, such as reliability to adversarial examples, transparency of decision-making, and communication facilitator. Howeve…

stat.ME2023

A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials

Tianyu Zhan

When designing confirmatory Phase 3 studies, one usually evaluates one or more efficacious and safe treatment option(s) based on data from previous studies. However, several retros…